UNPACKED

← Frontpage

**When Ozempic Meets the Protein Bar**

2h ago · 5 sources · trend

GLP-1 is no longer a niche pharma story. Around 13.3% of US consumers are using GLP-1 medications today, and adoption is projected to hit 21% by 2030. That already translates to roughly 40 million Americans on these drugs.

The industry fear was simple. Fewer cravings. Smaller baskets. Category collapse.

Experts at the ABA Convention see it differently. GLP-1s are reshaping how, when and how much people eat. Think smaller portions and more frequent eating occasions, not a mass exit from bakery and snacks.

Retail is adjusting in real time. Holland & Barrett just partnered with Phlo to signpost shoppers to clinically supervised weight management services, without prescribing medication. The demand is obvious. 55% of UK adults wish they could manage their weight better. 64% are actively managing it. 33% are actively trying to lose weight.

Here is the twist. Roughly 1 in 10 GLP-1 users develop at least one new nutritional deficiency after six months. Appetite goes down. Nutrient gaps can go up.

Now layer in healthy ageing. Nestlé has launched its first drinks line aligned with longevity, and the elderly nutrition market is expected to reach $43.1bn by 2032.

Why it matters. GLP-1 does not kill food demand. It changes the brief. Smaller formats. Higher nutrient density. Protein that actually delivers. In India, 45.9% of rural and 38.7% of urban consumers still rely on cereals for protein, and ITC says there is significant room for growth due to low-quality intake.

The next growth wave is not less food. It is smarter food. Brands that sell nourishment, not just calories, win.

Key facts

  • Around 13.3% of US consumers are using GLP-1 medications, with adoption projected to reach around 21% by 2030.
  • Approximately 40 million Americans are already using GLP-1 medications, which have been in use since the 1990s.
  • Holland & Barrett has partnered with GLP-1 provider Phlo to signpost customers in-store and online to clinically supervised weight management services, without prescribing medication.
  • Holland & Barrett’s data shows 55% of UK adults wish they could manage their weight better, 64% are actively managing their weight and 33% are actively trying to lose weight.
  • Research cited by Holland & Barrett indicates roughly one in 10 GLP-1 users develop at least one new nutritional deficiency after six months on the drug.
  • Healthy ageing is moving into mainstream food and drink, with Nestlé launching its first drinks line aligned with the healthy longevity trend.
  • The elderly nutrition market is expected to reach $43.1bn by 2032.
  • Experts at the ABA Convention said GLP-1s are reshaping how, when and how much people eat, with smaller portions and more frequent eating occasions rather than a mass exit from food categories.
  • In India, protein intake remains heavily cereal-based, with 45.9% of rural and 38.7% of urban consumers relying on cereals as a protein source.
  • ITC stated that despite increased competition, there is still significant room for growth in India’s protein sector due to inadequate and low-quality protein intake.
  • Growth Asia Summit 2026 will address the rise of GLP-1 therapies and active metabolic health as emerging opportunities in Asia’s nutrition sector.
  • 13.3%
  • 21%
  • 40 million
  • 55%
  • 64%
  • 33%
  • 1 in 10
  • $43.1bn

Coverage